Login
Home / BNTC : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Benitec Biopharma Inc.

$12.19 -$0.40 (-3.18%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$12.22
Day Range
$12.12$12.51
Year Range
$9.85$16.76
Market Cap
418.78M
AVG Volume
124.98K
Trailing/Forward PE
-10.98/-
PEG ratio
-0.49
Dividend Yield
-
Next Earnings Date
2026-09-28
Primary Exchange
NASDAQUS
Revenue (USD)
-200K0200K400K600K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Net Income (USD)
-20M-15M-10M-5M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Operating Income (USD)
-20M-15M-10M-5M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
EBITDA (USD)
-20M-15M-10M-5M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Cash Flows (USD)
-10M-7.5M-5M-2.5M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
EPS (USD)
-0.6-0.4-0.2-024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Expenses (USD)
05M10M15M20MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Cash & Debt (USD)
050M100M150M200MCashLong Term DebtShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Debt ratios
0123424 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Margins
-1000%0%1000%2000%21 Q221 Q321 Q422 Q222 Q323 Q223 Q323 Q424 Q425 Q4
Return on Capital
-60%-40%-20%0%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Shares Outstanding
020M40M60M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Dividends (USD)
00.511.52Jun 18
Employee Count
05101520202020212022202320242025
Book Value Per Share (USD)
0246824 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Total Assets (USD)
050M100M150M200M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
Free Cash Flow Yield
-20%-15%-10%-5%0%med -4.14%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
-150000-100000-50000050000med 841.04Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
02468med 3.65Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Benitec Biopharma Inc.
BNTC
Stockpicker

Video analysis: BNTC

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BNTC

AWM Investment Company Inc. Acquires New Position in Benitec Biopharma Limited $BNTC

defenseworld.net · 26 Aug 2026

AWM Investment Company Inc. Acquires New Position in Benitec Biopharma Limited $BNTC

AWM Investment Company Inc. acquired a new position in Benitec Biopharma Limited (NASDAQ: BNTC) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 187,977 shares of the biotechnology company's stock, valued at approximately $2,515,000. AWM Investment Company Inc. owned about 0.55% of

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.